title: Vasoreactive effects of hypothalamic sodium transport inhibitor.
authors.affiliation: Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff, UK.
authors.forename: M A
authors.initials: MA
authors.lastname: Mir
authors.forename: K
authors.initials: K
authors.lastname: Morgan
authors.forename: S
authors.initials: S
authors.lastname: Chappell
authors.forename: M
authors.initials: M
authors.lastname: Lewis
authors.forename: G
authors.initials: G
authors.lastname: Spurlock
authors.forename: P
authors.initials: P
authors.lastname: Collins
authors.forename: M
authors.initials: M
authors.lastname: Lewis
mesh_terms: D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism*; D066298:In Vitro Techniques; D010455:Peptides / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology*; D010477:Perfusion; D011817:Rabbits; D051381:Rats; D012964:Sodium / Q000378:metabolism*; D014662:Vasoconstrictor Agents
chemical_list: D010455:Peptides; D014662:Vasoconstrictor Agents; C029311:serum sodium transport inhibitor; D012964:Sodium; D002118:Calcium